Stay updated on Imatinib in Recurrent Psoriasis Clinical Trial
Sign up to get notified when there's something new on the Imatinib in Recurrent Psoriasis Clinical Trial page.

Latest updates to the Imatinib in Recurrent Psoriasis Clinical Trial page
- Check5 days agoNo Change Detected
- Check12 days agoChange DetectedEditorial edits to the Publications section clarify that publications are automatically populated from PubMed and may not all pertain to the study, and update the revision label to v3.3.2. The prior text stated that publications came from PubMed and listed revision as v3.2.0.SummaryDifference0.1%

- Check19 days agoChange DetectedRemoved the government funding status banner warning about potential delays in updates. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

- Check40 days agoChange DetectedThe differences shown in the screenshots seem to be cosmetic UI/layout changes without changes to the study's core details or data. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.5%

- Check62 days agoChange DetectedAdded a government funding lapse notice and a v3.2.0 version tag, replacing the prior v3.1.0.SummaryDifference4%

- Check69 days agoChange DetectedUpdates the page version from v3.0.2 to v3.1.0, indicating a new release.SummaryDifference0.1%

- Check83 days agoChange DetectedVersion bumped to v3.0.2 and the Back to Top link was removed; no substantive changes to core content, pricing, or availability.SummaryDifference0.2%

Stay in the know with updates to Imatinib in Recurrent Psoriasis Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Imatinib in Recurrent Psoriasis Clinical Trial page.